New Zealand King Salmon valuation analysis FY26

Investment Thesis: The 'Survival to Recovery' Pivot Verified Answer #1

New Zealand King Salmon Investments Ltd (NZK.NZX) has effectively transitioned from an acute survival phase, characterized by catastrophic mortality events in FY2022, to a stable recovery phase as of August 2026. Verified Answer #1

The investment thesis rests on three pillars: (1) Operational Optimization: The successful implementation of summer-specific feed diets and operational execution has stabilized biological performance, directly impacting yield and feed conversion ratios. (2) Earnings Momentum: Management has delivered consecutive guidance upgrades in FY26 (most recently on August 6, 2026), demonstrating improved margins and volume predictability. (3) Strategic Growth: The pilot launch of the 'Blue Endeavour' project and the commissioning of new wellboat infrastructure (e.g., the Ronja King) provide a pathway to scaling production volumes from FY27 onwards, though near-term supply chain cost pressures remain a constraint. Verified Answer #1

Financial & Operational Performance Verified Answer #1

Financial Results (1HY26): The company reported a significant turnaround for the six months ended March 31, 2026, with a net profit of NZD 13.8 million (a marked improvement from the loss posted in the prior corresponding period) and pro-forma EBITDA of NZD 17.2 million. Verified Answer #1

FY26 Guidance Upgrade: As of August 6, 2026, NZK raised its FY26 pro-forma EBITDA guidance to NZD 30 million–34 million (up from previous guidance of NZD 23 million–29 million). Verified Answer #1

Expected harvest volume has been tightened to 5,950–6,050 metric tonnes[4][5]. Verified Answer #1

Biological Performance & Mortality: Historically, high summer water temperatures led to mortality rates as high as 42% (notably in FY2022). Verified Answer #1

The current recovery is driven by a reduction in these mortality rates through targeted summer diets and improved stock grading. Verified Answer #1

This reduction is the primary driver of the improved margins and higher sales volumes[6][7]. Verified Answer #1

Valuation Model (Projected) Verified Answer #1

*Note: Valuation in aquaculture is sensitive to biomass estimates and biological risks. Verified Answer #1

Projections assume current operational stability is maintained.* Verified Answer #1

Methodology: We apply an EV/EBITDA multiple approach, typical for the aquaculture industry. Verified Answer #1

Assuming an industry-standard multiple of 6.0x–7.0x (adjusted for NZK's specific recovery profile) on the midpoint FY26 EBITDA guidance of NZD 32 million, we estimate an Enterprise Value (EV) in the range of NZD 192 million – 224 million. Verified Answer #1

| Horizon | Target Rationale | Price/Valuation Context | | :--- | :--- | :--- | | 1-Year Target | Focus on confirming the consistency of mortality reduction and EBITDA conversion. Verified Answer #1

Assuming stable pricing, target EBITDA ~NZD 35M-38M in FY27. | Estimate: 20-25% upside from current levels as market realizes earnings stability. | | 5-Year Target | Contingent on the scaling of Blue Endeavour and successful expansion into deeper water aquaculture (mitigating future mortality risk). | Highly speculative: potential for 50-80% upside if full production scaling succeeds without biological disruption. | Verified Answer #1

Investment Recommendation: Accumulate / Hold Verified Answer #1

Recommendation: Accumulate for patient investors; Hold for existing positions. Verified Answer #1

Rationale: The company has de-risked its biological operational model significantly. Verified Answer #1

The primary risk factor remains the inherent volatility of salmon farming (mortality and environmental variables). Verified Answer #1

Investors should monitor the progress of Blue Endeavour closely, as it is the key long-term volume driver. Verified Answer #1

Near-term earnings growth is likely to be tempered by the necessary reinvestment into growth initiatives, which may dampen free cash flow in FY27 despite higher production[4][5]. Verified Answer #1

Risk Factors: Verified Answer #1

Biological Volatility: Despite recent successes, environmental changes (e.g., marine heatwaves) remain an existential risk. Verified Answer #1

Supply Chain: Inflationary pressure on feed and logistics costs is expected to persist into FY27[3]. Verified Answer #1

Execution: Transitioning from a pilot phase to full-scale operations at new sites involves significant capital expenditure and potential technical challenges. Verified Answer #1

Sources: [1] nzx.com [2] bairdmaritime.com [3] marketindex.com.au [4] moomoo.com [5] nzx.com [6] seafoodsource.com [7] smallcaps.com.au Verified Answer #1